Azərbaycanca
Deutsch
English
Français
Русский
ภาษาไทย
Українська
This article relies excessively on references to primary sources. (October 2023) |
The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) is a trade association that represents internationally over 90 pharmaceutical companies and associations around the world. IFPMA is based in Geneva and is in official relations with the United Nations where it contributes industry expertise to global health discussions.
| Abbreviation | IFPMA |
|---|---|
| Formation | 1968 |
| Type | Trade association |
| Headquarters | Geneva, Switzerland |
President | Dr Thomas Schinecker, CEO, Roche Group |
Key people | Dr Thomas Schinecker (President) Dr David Reddy (Director General) |
| Website | https://www.ifpma.org/ |
It was formed in 1968 and is based in Geneva, Switzerland.
In 2019, IFPMA released a strengthened code of ethics and professional standards. Among the revisions to the code is a prohibition on gifts provided to healthcare professionals. The code revision has been followed by – an open-source, continuously evolving resource that contains diverse guidance designed to keep pace with emerging developments.
The pharmaceutical industry contributes to the Sustainable Development Goals (SDGs), in particular Goal 3 to ensure healthy lives and promote well-being for all at all ages. Today over 35 IFPMA member companies contribute resources and know-how to SDG initiatives partnering with academia, development organizations, NGOs, foundations and other business sectors. There are over 250 collaborations that aim to strengthen health systems and expand quality healthcare access.
IFPMA works in partnership with other members of the global health community to achieve Universal Health Coverage (UHC) targets and contribute to a world where no one is left behind in receiving the healthcare they need. A wide range of stakeholders across the public and private sectors have an opportunity to collaborate more closely to increase affordability of and access to essential medicines, and the low-cost, but highly effective, interventions and screenings.
Leadership
The President of IFPMA is Dr Thomas Schinecker, CEO, Roche Group. Robert M. Davis, Chairman and CEO of Merck & Co., and Hiroyuki Okuzawa, President and CEO, Daiichi Sankyo, serve as Vice-Presidents.
See also
- Association of the British Pharmaceutical Industry
- European Federation of Pharmaceutical Industries and Associations Europe
- Interpharma Switzerland
- Innovative Pharmaceutical Association South Africa
- The Japan Pharmaceutical Manufacturers Association
- Les entreprises du médicament France
References
- "International Federation of Pharmaceutical Manufacturers & Associations - IFPMA". Retrieved 2 November 2023.
- "List of NGOs accredited at the UN Office at Geneva". Retrieved 7 December 2022.
- "About IFPMA". Archived from the original on 26 June 2014. Retrieved 11 Jun 2014.
- "New International Pharmaceutical Practice Code Tightens Restrictions on Gifts". Ropes & Gray. 27 February 2019. Retrieved 30 October 2023.
- Underwood, George (18 Mar 2020). "Industry and patient groups collaborate on new guidance for interaction". Retrieved 7 December 2022.
- Baker, Berry (20 December 2018). "IFPMA launches new Code of Practice for the pharmaceutical industry". Pharma Technology. Retrieved 30 October 2023.
- Lugogo, Mwana (24 April 2023). "Industry and patient groups collaborate on new guidance for interaction". PharmaBoardroom. Retrieved 30 October 2023.
- "Goal 3: Ensure healthy lives and promote well-being for all at all ages". United Nations. Retrieved 30 October 2023.
- Explore Collaborations Global Health Progress 2023,https://globalhealthprogress.org/explore-our-collaborations/
- "Global Health Progress is an interactive resource hub highlighting collaborations between the innovative biopharmaceutical industry and our partners to support the SDGs". 18 Mar 2022. Retrieved 7 December 2022.
- "Private Sector Commitments To Universal Health Coverage, UHC2030 Private Sector Constituency 2023 Statement" (PDF). UHC2030. Retrieved 30 October 2023.
- "The Road to 2030: Revitalizing Multi-sectoral Partnerships to Achieve Universal Health Coverage". Foreign Policy Analytics. Retrieved 30 October 2023.
- "Roche CEO named as new president of IFPMA". www.thepharmaletter.com. Retrieved 2024-11-27.
- EFPIA, https://www.ifpma.org/members/efpia/
- Interpharma, https://www.ifpma.org/members/interpharma/
- IPASA, https://www.ifpma.org/members/ipasa/
- JPMA, https://www.ifpma.org/members/jpma/
- LEEM, https://www.ifpma.org/members/leem/
External links
- Official website
![image]()
Author: www.NiNa.Az
Publication date:
wikipedia, wiki, book, books, library, article, read, download, free, free download, mp3, video, mp4, 3gp, jpg, jpeg, gif, png, picture, music, song, movie, book, game, games, mobile, phone, android, ios, apple, mobile phone, samsung, iphone, xiomi, xiaomi, redmi, honor, oppo, nokia, sonya, mi, pc, web, computer
This article relies excessively on references to primary sources Please improve this article by adding secondary or tertiary sources Find sources International Federation of Pharmaceutical Manufacturers amp Associations news newspapers books scholar JSTOR October 2023 Learn how and when to remove this message The International Federation of Pharmaceutical Manufacturers amp Associations IFPMA is a trade association that represents internationally over 90 pharmaceutical companies and associations around the world IFPMA is based in Geneva and is in official relations with the United Nations where it contributes industry expertise to global health discussions International Federation of Pharmaceutical Manufacturers amp AssociationsAbbreviationIFPMAFormation1968TypeTrade associationHeadquartersGeneva SwitzerlandPresidentDr Thomas Schinecker CEO Roche GroupKey peopleDr Thomas Schinecker President Dr David Reddy Director General Websitehttps www ifpma org It was formed in 1968 and is based in Geneva Switzerland In 2019 IFPMA released a strengthened code of ethics and professional standards Among the revisions to the code is a prohibition on gifts provided to healthcare professionals The code revision has been followed by an open source continuously evolving resource that contains diverse guidance designed to keep pace with emerging developments The pharmaceutical industry contributes to the Sustainable Development Goals SDGs in particular Goal 3 to ensure healthy lives and promote well being for all at all ages Today over 35 IFPMA member companies contribute resources and know how to SDG initiatives partnering with academia development organizations NGOs foundations and other business sectors There are over 250 collaborations that aim to strengthen health systems and expand quality healthcare access IFPMA works in partnership with other members of the global health community to achieve Universal Health Coverage UHC targets and contribute to a world where no one is left behind in receiving the healthcare they need A wide range of stakeholders across the public and private sectors have an opportunity to collaborate more closely to increase affordability of and access to essential medicines and the low cost but highly effective interventions and screenings LeadershipThe President of IFPMA is Dr Thomas Schinecker CEO Roche Group Robert M Davis Chairman and CEO of Merck amp Co and Hiroyuki Okuzawa President and CEO Daiichi Sankyo serve as Vice Presidents See alsoAssociation of the British Pharmaceutical Industry European Federation of Pharmaceutical Industries and Associations Europe Interpharma Switzerland Innovative Pharmaceutical Association South Africa The Japan Pharmaceutical Manufacturers Association Les entreprises du medicament FranceReferences International Federation of Pharmaceutical Manufacturers amp Associations IFPMA Retrieved 2 November 2023 List of NGOs accredited at the UN Office at Geneva Retrieved 7 December 2022 About IFPMA Archived from the original on 26 June 2014 Retrieved 11 Jun 2014 New International Pharmaceutical Practice Code Tightens Restrictions on Gifts Ropes amp Gray 27 February 2019 Retrieved 30 October 2023 Underwood George 18 Mar 2020 Industry and patient groups collaborate on new guidance for interaction Retrieved 7 December 2022 Baker Berry 20 December 2018 IFPMA launches new Code of Practice for the pharmaceutical industry Pharma Technology Retrieved 30 October 2023 Lugogo Mwana 24 April 2023 Industry and patient groups collaborate on new guidance for interaction PharmaBoardroom Retrieved 30 October 2023 Goal 3 Ensure healthy lives and promote well being for all at all ages United Nations Retrieved 30 October 2023 Explore Collaborations Global Health Progress 2023 https globalhealthprogress org explore our collaborations Global Health Progress is an interactive resource hub highlighting collaborations between the innovative biopharmaceutical industry and our partners to support the SDGs 18 Mar 2022 Retrieved 7 December 2022 Private Sector Commitments To Universal Health Coverage UHC2030 Private Sector Constituency 2023 Statement PDF UHC2030 Retrieved 30 October 2023 The Road to 2030 Revitalizing Multi sectoral Partnerships to Achieve Universal Health Coverage Foreign Policy Analytics Retrieved 30 October 2023 Roche CEO named as new president of IFPMA www thepharmaletter com Retrieved 2024 11 27 EFPIA https www ifpma org members efpia Interpharma https www ifpma org members interpharma IPASA https www ifpma org members ipasa JPMA https www ifpma org members jpma LEEM https www ifpma org members leem External linksOfficial website